Followers | 0 |
Posts | 1151 |
Boards Moderated | 0 |
Alias Born | 07/10/2003 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, September 01, 2003 7:56:51 AM
From the Leukemia and Lymphoma Society 2001 Annual Report: Research Grant recipient Matthew J.Thomas, PhD –1999 University of South Florida.
Yiwen He, Michael K Armanious, Matthew J Thomas & W Douglas Cress. Identification of E2F-3B, an alternative form of E2F-3 lacking a conserved N-terminal region. Oncogene 13 July 2000, Volume 19, Number 30.
Matthew J. Thomas, Angelina A. Platas, and Diane K. Hawley. Transcriptional Fidelity and Proofreading by RNA Polymerase II. Cell May 15, 1998: 93 (4).
Matthew J. Thomas, Edward Seto. Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? Gene Volume 236, Issue 2, Page 197-355 (20 August 1999).
FEATURED Element79 Gold Corp Provides Update on Nevada Portfolio • Aug 23, 2024 8:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM